Catalent Pharma Solutions acquires cell and gene therapy CDMO MaSTherCell

Drug manufacturer Catalent Pharma Solutions has wrapped up its previously announced $315 million acquisition of MaSTherCell Global, a technology-focused cell and gene therapy contract development ... Read More